Alumni around the world are invited to join us virtually for a lecture on the future of cancer care. Our host, London Branch President Danielle Vanhie, Artsci’09, will be joined by Dr. Jane Philpott, Dean of Queen's Health Sciences and Director of the School of Medicine, who will share the latest news about health sciences at Queen's.
The special lecture will be delivered by cancer care expert Dr. Chris Booth, Artsci'97, Meds'01, Professor in the Department of Oncology and Department of Public Health Sciences and Canada Research Chair in Population Cancer Care. An internationally-recognized cancer researcher and medical oncologist, Dr. Booth is uniquely positioned to explain how our health systems - and patient care - can be dramatically improved.
About the Speakers
Dean Jane Philpott
Dr. Jane Philpott is the Dean of the Faculty of Health Sciences, Director of the School of Medicine at Queen's University, and CEO of the Southeastern Ontario Academic Medical Organization. She is a medical doctor, a Professor of Family Medicine, and former Member of Parliament. Prior to politics, Jane spent the first decade of her medical career in Niger, West Africa. She was a family doctor in Markham-Stouffville for 17 years and became Chief of Family Medicine at Markham Stouffville Hospital in 2008. From 2015 to 2019 she served as federal Minister of Health, Minister of Indigenous Services, President of the Treasury Board and Minister of Digital Government. She currently serves as the Ministers' Special Advisor for the Ontario Health Data Platform and was recently elected to the Canadian Academy of Health Sciences.
Dr. Chris Booth, Artsci’97, Meds’01
Dr. Booth presents cancer care's biggest challenges and solutions, drawing upon ground-breaking research in the value, access, and quality of cancer care in Canada and globally. Dr. Booth serves as part of the World Health Organization's Essential Medicine List Cancer Working Group and as an Advisor (Health Services Research) to the National Cancer Grid of India. In his clinical practice, he provides care to patients with gastrointestinal cancers. From his research focus to his frontline duties, Dr. Booth is a determined advocate for compassion and quality in cancer care.
